Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.

Weber BH, Vogt G, Pruett RC, Stöhr H, Felbor U.

Nat Genet. 1994 Dec;8(4):352-6.

PMID:
7894485
2.

TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.

Li Z, Clarke MP, Barker MD, McKie N.

Expert Rev Mol Med. 2005 Oct 31;7(24):1-15. Review.

PMID:
16259644
3.

[Sorsby's fundus dystrophy. A genetically homogeneous disease].

Felbor U, Weber BH.

Ophthalmologe. 1998 May;95(5):287-90. German.

PMID:
9643018
4.

Genomic organization of the human tissue inhibitor of metalloproteinases-3 (TIMP3)

Stöhr H, Roomp K, Felbor U, Weber BH.

Genome Res. 1995 Dec;5(5):483-7.

5.
6.

A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.

Felbor U, Stöhr H, Amann T, Schönherr U, Apfelstedt-Sylla E, Weber BH.

J Med Genet. 1996 Mar;33(3):233-6.

7.

Sorsby's fundus dystrophy is genetically linked to chromosome 22q13-qter.

Weber BH, Vogt G, Wolz W, Ives EJ, Ewing CC.

Nat Genet. 1994 Jun;7(2):158-61.

PMID:
7920634
8.

Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies.

Felbor U, Doepner D, Schneider U, Zrenner E, Weber BH.

Invest Ophthalmol Vis Sci. 1997 May;38(6):1054-9.

PMID:
9152224
9.

Exclusion of TIMP3 as a candidate locus in age-related macular degeneration.

De La Paz MA, Pericak-Vance MA, Lennon F, Haines JL, Seddon JM.

Invest Ophthalmol Vis Sci. 1997 May;38(6):1060-5.

PMID:
9152225
11.

A novel Ser156Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy with unusual clinical features.

Felbor U, Stöhr H, Amann T, Schönherr U, Weber BH.

Hum Mol Genet. 1995 Dec;4(12):2415-6. No abstract available.

PMID:
8634721
12.

A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy.

Langton KP, McKie N, Curtis A, Goodship JA, Bond PM, Barker MD, Clarke M.

J Biol Chem. 2000 Sep 1;275(35):27027-31.

14.
15.
16.

Sorsby's fundus dystrophy in two Japanese families with unusual clinical features.

Isashiki Y, Tabata Y, Kamimura K, Ohba N.

Jpn J Ophthalmol. 1999 Nov-Dec;43(6):472-80.

PMID:
10672875
17.

Sorsby's fundus dystrophy in the British Isles: demonstration of a striking founder effect by microsatellite-generated haplotypes.

Wijesuriya SD, Evans K, Jay MR, Davison C, Weber BH, Bird AC, Bhattacharya SS, Gregory CY.

Genome Res. 1996 Feb;6(2):92-101.

18.

A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy.

Lin RJ, Blumenkranz MS, Binkley J, Wu K, Vollrath D.

Am J Ophthalmol. 2006 Nov;142(5):839-48. Epub 2006 Sep 20.

PMID:
16989765
20.

Night blindness in Sorsby's fundus dystrophy reversed by vitamin A.

Jacobson SG, Cideciyan AV, Regunath G, Rodriguez FJ, Vandenburgh K, Sheffield VC, Stone EM.

Nat Genet. 1995 Sep;11(1):27-32.

PMID:
7550309

Supplemental Content

Support Center